Life and death by death receptors

Death receptors are members of the tumor necrosis factor receptor superfamily characterized by a cytoplasmic region known as the "death domain" that enables the receptors to initiate cytotoxic signals when engaged by cognate ligands. Binding to the ligand results in receptor aggregation an...

Full description

Saved in:
Bibliographic Details
Published in:The FASEB journal Vol. 23; no. 6; pp. 1625 - 1637
Main Authors: Guicciardi, Maria Eugenia, Gores, Gregory J
Format: Journal Article
Language:English
Published: United States The Federation of American Societies for Experimental Biology 01-06-2009
Federation of American Societies for Experimental Biology
Subjects:
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Death receptors are members of the tumor necrosis factor receptor superfamily characterized by a cytoplasmic region known as the "death domain" that enables the receptors to initiate cytotoxic signals when engaged by cognate ligands. Binding to the ligand results in receptor aggregation and recruitment of adaptor proteins, which, in turn, initiates a proteolytic cascade by recruiting and activating initiator caspases 8 and 10. Death receptors were once thought to primarily induce cytotoxic signaling cascades. However, recent data indicate that they initiate multiple signaling pathways, unveiling a number of nonapoptosis-related functions, including regulation of cell proliferation and differentiation, chemokine production, inflammatory responses, and tumor-promoting activities. These noncytotoxic cascades are not simply a manifestation of inhibiting proapoptotic pathways but are intrinsically regulated by adaptor protein and receptor internalization processes. Insights into these various death receptor signaling pathways provide new therapeutic strategies targeting these receptors in pathophysiological processes.--Guicciardi, M. E., Gores, G. J. Life and death by death receptors.
Bibliography:ObjectType-Article-2
SourceType-Scholarly Journals-1
ObjectType-Feature-3
content type line 23
ObjectType-Review-1
Correspondence: College of Medicine, Mayo Clinic, 200 First St. SW, Rochester, MN 55905, USA. E-mail: gores.gregory@mayo.edu
ISSN:0892-6638
1530-6860
DOI:10.1096/fj.08-111005